Quercetin elevates p27Kip1 and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1

Oncogene

Volumn 22, Issue 35, 2003, Pages 5504-5514

  Beniston, Richard Garry ^a   Campo, Maria Saveria ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cell cycle; HFK; HPV E6 E7; P27Kip1; Quercetin

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; MESSENGER RNA; MUTAGENIC AGENT; ONCOPROTEIN; PROTEIN P27; QUERCETIN; VIRUS PROTEIN;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; FERN; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KERATINOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; WART VIRUS;

CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE; HUMANS; KERATINOCYTES; MUTAGENS; ONCOGENE PROTEINS, VIRAL; PTERIDIUM; QUERCETIN; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 4; DNA VIRUSES; FILICOPHYTA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE; PTERIDIUM; PTERIDIUM AQUILINUM;

EID: 0042836586     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206848     Document Type: Article

References (66)

1. Alonso-Amelot ME and Avendano M. (2001). Int. J. Cancer, 91, 252-259.
2. Alonso-Amelot ME, Castillo U, Smith BL and Lauren DR. (1996). Nature, 382, 587.
3. Arber N, Shapira I, Ratan J, Stern B, Hibshoosh H, Moshkowitz M, Gammon M, Fabian I and Halpern Z. (2000). Gastroenterology, 118, 1045-1050.
4. Ashby ADM, Meagher L, Campo MS and Finbow ME. (2001). J. Gen. Virol., 82, 2353-2362.
5. Beniston RG, Morgan IM, O'Brien V and Campo MS. (2001). Carcinogenesis, 22, 1069-1076.
6. Bjieldanes LF and Chang GW. (1977). Science, 197, 557-561.
7. Boyer SN, Wazer DE and Band V. (1996). Cancer Res., 56, 4620-4624.
8. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T. (1998). Nature, 291, 597-601.
9. Cairney M and Campo MS. (1995). Carcinogenesis, 16, 1997-2001.
10. Campo MS, O'Neil BW, Barron RJ and Jarrett WF. (1994). Carcinogenesis, 15, 1597-1601.
11. Carrano AC, Eytan E, Hershko A and Pagano M. (1999). Nat. Cell Biol., 1, 193-199.
12. Casagrande F and Darbon JM. (2001). Biochem. Pharmacol., 61, 1205-1215.
13. Casson AG, Wilson SM, McCart JA, O'Malley FP, Ozcelik H, Tsao MS and Chambers AF. (1997). Int. J. Cancer, 72, 739-745.
14. Chang F, Syrjanen S, Shen Q, Ji H and Syrjanen K. (1990). Int. J. Cancer, 45, 21-25.
15. Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee YS and Lee SJ. (2001). Int. J. Cancer, 19, 837-844.
16. Conrad M, Bubb VJ and Schlegel R. (1993). J. Virol., 67, 6170-6178.
17. Cooper K, Taylor L and Govind S. (1995). J. Pathol., 175, 273-277.
18. Davies SP, Reddy H, Caivano M and Cohen P. (2000). Biochem. J., 351, 95-105.
19. De Villiers EM, Lavergne D, Chang F, Syrjanen K, Tosi P, Cintorino M, Santopietro R and Syrjanen S. (1999). Int. J. Cancer, 81, 225-228.
20. Dell G and Gaston K. (2001). Cell. Mol. Life Sci., 58, 1923-1942.
21. Fazal F, Rahman A, Greensill J, Ainley K, Hadi SM and Parish JH. (1990). Carcinogenesis, 11, 2005-2008.
22. Funk JO, Waga S, Harry JB, Espling E, Stillman B and Galloway DA. (1997). Genes Dev., 11, 2090-2100.
23. Galiana C, Lozano JC, Bancel B, Nakazawa H and Yamasaki H. (1995). Mol. Carcinog., 14, 286-293.
24. Galpin OP, Whitaker CJ, Whitaker RH and Kassab JY. (1990). Br. J. Cancer, 61, 737-740.
25. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, David RW, Viglione M, Symer DE, Shah KV and Sidransky D. (2000). J. Nat. Cancer Inst., 92, 709-720.
26. Hara T, Kamura T, Nakayama K, Oshikawa K, Hatakeyama S and Nakayama K-I. (2001). J. Biol. Chem., 276, 48937-48943.
27. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR and Schiller JT. (1989). EMBO J., 8, 3905-3910.
28. Hirayama T. (1979). Nutr. Cancer, 1, 67-81.
29. Hirono I, Ogino H, Fujimoto M, Yamada K, Yoshida Y, Ikagawa M and Okumura M. (1987). J. Natl. Cancer Inst., 79, 1143-1149.
30. Ishidate Jr M, Harnois MC and Sofuni T. (1988). Mutat. Res., 195, 151-213.
31. Iwashita K, Kobori M, Yamaki K and Tsushida T. (2000). Biosci. Biotechnol. Biochem., 64, 1813-1820.
32. Jackson ME and Campo MS. (1995). DNA Tumour Viruses: Oncogenic Mechanisms. Barbanti-Brodano G (ed). Plenum Press: New York.
33. Jackson ME, Pennie WD, McCaffery RE, Smith KT, Grindlay GJ and Campo MS. (1991). Mol. Carcinog., 4, 382-387.
34. Jones DL, Alani RM and Munger K. (1997a). Genes Dev., 11, 2102-2111.
35. Jones DL, Thompson DA and Munger K. (1997b). Virology, 239, 97-107.
36. Liang Y, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee J-H, Ciarallo S, Catzavelos C, Beniston R, Franssen E and Slingerland JM. (2002). Nat. Med., 10, 1163-1180.
37. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC and Scheithauer BW. (1999). Am. J. Pathol., 154, 313-323.
38. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakidis TR and Roberts JM. (2001). Nature, 413, 323-327.
39. Mantovani F and Banks L. (2001). Oncogene, 20, 7874-7887.
40. Marliere CA, Wathern P, Freitas RN, Castro MCFM and Galvao MAM. (2000). Bracken Fern: Toxicity, Biology and Control. Taylor JA, Smith RT (eds). The International Braekeu Group, Aberystwyth, Dyfed, Wales, pp. 144-149.
41. Martin LG, Demers W and Galloway DA. (1998). J. Virol., 72, 975-985.
42. Matoba M, Saito E, Saito K, Koyama K, Natori S, Matsushima T and Takimoto M. (1987). Mutagenesis, 2, 419-423.
43. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL. (2001). Oncogene, 20, 7888-7898.
44. Nakayama K-I, Hatakeyama S and Nakayama K. (2001). Biochem. Biophys. Res. Comm., 282, 853-860.
45. Nakayasu M, Sakamoto H, Terada M, Nagao M and Sugimura T. (1986). Mutat. Res., 174, 79-83.
46. Oelze I, Kartenbeck J, Crusius K and Alonso A. (1995). J. Virol., 69, 4489-4494.
47. Pennie WD and Campo MS. (1992). Virology, 190, 861-865.
48. Plaumann B, Fritsche M, Rimpler H, Brandner G and Hess RD. (1996). Oncogene, 13, 1605-1614.
49. Potter DM and Baird MS. (2000). Br. J. Cancer, 83, 914-920.
50. Reinstein E, Scheffner M, Oren M, Ciechanover A and Schwartz A. (2000). Oncogene, 19, 5944-5950.
51. Rong Y, Yang EB, Zhang K and Mack P. (2000). Anticancer Res., 20, 4339-4345.
52. Sano T, Masuda N, Oyama T and Nakajima T. (2002). Pathol. Int., 52, 375-383.
53. Sherr CJ and Roberts JM. (1999). Genes Dev., 13, 1501-1512.
54. Sorsdahl K, Casson AG, Troster M, Van Mayel D, Inculet R and Chambers AF. (1994). Cancer Detect. Prev., 18, 179-185.
55. Straight SW, Herman B and McCance DJ. (1995). J. Virol., 69, 3185-3192.
56. Suzuk L, Noffsinger AE, Hui YZ and Fenoglio-Preiser CM. (1996). Cancer, 78, 704-710.
57. Suzuki S, Takada T, Sugawara Y, Muto T and Kominami R. (1991). Jpn. J. Cancer Res., 82, 1061-1064.
58. Syrjanen KJ. (2002). J. Clin. Pathol., 55, 721-728.
59. Togawa K, Jaskiewicz K, Takahashi H, Meltzer SJ and Rustgi AK. (1994). Gastroenterology, 107, 128-136.
60. Vance KW, Campo MS and Morgan IM. (1999). J. Biol. Chem., 274, 27839-27844.
61. Villalobos-Salazar J, Mora J, Meneses A and Pashov B. (1995). "Bracken, an Environmental Issue." Smith RT, Taylor A (eds). The International Braekeu Group, Aberystwyth, Dyfed, Wales, pp. 102-103.
62. Yamashita N and Kawanishi S. (2000). Free Radic. Res., 33, 623-633.
63. Zehbe I, Rätsch A, Alunni-Fabbroni M, Burzlaff A, Bakos E, Dürst M, Wilander E and Tommasino M. (1999). Oncogene, 18, 2201-2211.
64. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW and Jansen-Durr P. (1996). Oncogene, 13, 2323-2330.
65. Zur Hausen H. (1996). Biochem. Biophys. Acta, 1288, F55-F78.
66. Zur Hausen H. (2000). J. Natl. Cancer Inst., 92, 690-698.